THE GENETIC ROLE IN RISK FACTORS AND DISEASE PROGRESSION OF OSTEOARTHRITIS

Thị Thùy Trang Huỳnh, Thị Kim Phi Trần, Hoàng Phương Thư Vũ

Main Article Content

Abstract

Osteoarthritis (OA) is the most common joint disease worldwide, characterized by cartilage degeneration, subchondral bone changes, and damage to periarticular structures. The illness typically worsens over time, resulting in pain, decreased mobility, and a lower quality of life along with a significant financial burden. Currently, treatment strategies for OA mainly focus on symptom relief and functional improvement, whereas disease progression remains irreversible. Because of the intricate interactions between mechanical, metabolic, inflammatory, and genetic factors, the pathophysiology of OA remains unclear despite a great deal of research. In recent years, molecular biology studies have gained increasing attention in elucidating the underlying mechanisms. Specifically, genetic research has become a new method that clarifies the role of heredity in interindividual variability and disease susceptibility, as well as its potential uses in early diagnosis and the creation of new treatment.

Article Details

References

1. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023; 5, p508–p522.
2. Sharon L Kolasinski, American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee 2019
3. Nur Aimi Asyrani Zamri. Prevalence, Risk Factors and Primary Prevention of Osteoarthritis in Asia: A Scoping Review. Elderly Health Journal. 2019; 5(1): 19-31.
4. Ansok, C.B.; Muh, S.J. Optimal management of glenohumeral osteoarthritis. Orthop. Res. Rev. 2018, 10, 9–18.
5. Ho-Pham LT, Lai TQ, Mai LD, Doan MC, Pham HN, et al. (2014) Prevalence of Radiographic Osteoarthritis of the Knee and Its Relationship to Self Reported Pain. PLoS ONE. 9(4): e94563.doi:10.1371/journal.pone.0094563
6. G. Aubourg, S.J. Rice, P. Bruce-Wootton, J. Loughlin. Genetics of osteoarthritis. Osteoarthritis and cartilage, 2022, 30, 636-649
7. Loughlin J, Mustafa Z, Smith A, et al. Linkage analysis of chromosome 2q in osteoarthritis. Arthritis Rheum. 1999;42(9):1902–1906.
8. Miyamoto Y, Mabuchi A, Shi D, et al. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet. 2007;39(4):529–533.
9. Kajetan Kiełbowski eat al. The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis. International Journal Molecular Sciences. 2023, 24, 11655. https://doi.org/10.3390/ijms241411655
10. Xinyu Li et al. New treatment for osteoarthritis: Gene therapy. Precision Clinical Medicine, 2023, 6: pbad014. DOI: 10.1093/pcmedi/pbad014